Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market

Carotech Enters into Exclusive Arrangement with Metagenics for Tocomin® SupraBio(TM) for the Healthcare Practitioner Market Company has entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBio(TM) – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Martek Announces New Infant Formula Licensee Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea. Martek Announces New Infant Formula Licensee Company announces that South Korean infant formula market leader, Namyang Dairy Products Co., Ltd., has signed a license and supply agreement for rights to use Martek's docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formula sold in South Korea. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Bayer Pharma Signs Agreement with Vitiva Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts. Notice of Request for Proposals for Stevia rebaudiana Cultivars Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product. Notice of Request for Proposals for Stevia rebaudiana Cultivars Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product. Notice of Request for Proposals for Stevia rebaudiana Cultivars Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product. Notice of Request for Proposals for Stevia rebaudiana Cultivars Agriculture and Agri-Food Canada is offering an RFP for the licensed right to produce and market Stevia rebaudiana cultivars, seed and/or product. New Patent Promotes Soy Isoflavone Benefits The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls. New Patent Promotes Soy Isoflavone Benefits The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls. New Patent Promotes Soy Isoflavone Benefits The U.S. Patent Office has issued patent number 7,045,155 to Novogen, Ltd; This patent, which Acatris has exclusively licensed, protects compositions for the amelioration of human health conditions that are responsive to treatment with phyto-estrogens. The compositions comprise phytoestrogen-enriched extracts primarily from soy hypocotyls. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America. NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease NZyme Pharmaceuticals(TM), Inc. Unveils New Patent for Subtilisin NAT Applications in Decreasing Blood Viscosity Company announces a patent pending application for NZyme brand (Subtilisin NAT) for decreasing whole blood viscosity in the central therapeutic role of preventing and treating vascular disease Fuji Chemical Granted Inflammation Patent For Astaxanthin Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin. Fuji Chemical Granted Inflammation Patent For Astaxanthin Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin. Fuji Chemical Granted Inflammation Patent For Astaxanthin Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Provexis Announces Exclusivity Agreement Company has entered into an exclusivity agreement for a period of 12 months with a major global branded food business for the joint development and use of its patented Fruitflow(TM) heart-health technology. Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient. Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient. Sabinsa Corporation Granted U.S. Patent for Garcitrin(R) Ingredient Company has been issued U.S. patent #7,063,861, entitled "Bioavailable Composition of Natural and Synthetic HCA" for the company's Garcitrin(R) ingredient. Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved. Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved. Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved. Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved. Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder. Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder. Nutri Pharmaceuticals Research Inc. Introduces Near Odorless O2P(TM) DHA Available in Both Liquid Oil and Dry Powder Forms Company has announced the introduction of a near odorless and tasteless DHA oil and companion dry powder. Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales. Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales. Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales. Rowe Farm Meats and Investeco Capital announce investment partnership to grow naturally-raised foods company Rowe Farm Meats has announced that Investeco Capital has made a significant investment in the company to increase awareness of naturally-raised food, develop new products and increase productivity and sales. Burcon granted European patent Company has been granted a patent by the European Patent Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" - which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof. Burcon granted European patent Company has been granted a patent by the European Patent Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" - which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof. Burcon granted European patent Company has been granted a patent by the European Patent Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" - which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof. Burcon granted European patent Company has been granted a patent by the European Patent Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" - which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof. Burcon granted European patent Company has been granted a patent by the European Patent Office: European Patent No. 1434493 - "Flax Protein Isolate and Production" - which covers a novel protein isolate derived from any flax oil seed, including the low linolenic acid variety Linola(TM) oil seed, and the production thereof. AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements. AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements. AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements. AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements. AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements. AQUANOVA Receives Frost & Sullivan Award for its Pioneering Solubilisation Technology Frost & Sullivan has awarded the “2006 Excellence in Technology Award” to Aquanova German Solubilisate Technologies (AGT) GmbH for developing the highly sophisticated solubilisation technology, based on nanoscaled encapsulation of nutrients and ingredients, for functional foods and dietary supplements. Chrysantis Granted Zeaxanthin Esters Patent The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters. Chrysantis Granted Zeaxanthin Esters Patent The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters. Chrysantis Granted Zeaxanthin Esters Patent The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters. SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders UTEK Corporation and MM2 Group, Inc. Announce Strategic Alliance UTEK Corporation and and MM2 Group, Inc., a financial consulting group focused on nutraceuticals, are pleased to announce that they have signed a strategic alliance agreement to identify and potentially transfer proprietary technologies. UTEK Corporation and MM2 Group, Inc. Announce Strategic Alliance UTEK Corporation and and MM2 Group, Inc., a financial consulting group focused on nutraceuticals, are pleased to announce that they have signed a strategic alliance agreement to identify and potentially transfer proprietary technologies. UTEK Corporation and MM2 Group, Inc. Announce Strategic Alliance UTEK Corporation and and MM2 Group, Inc., a financial consulting group focused on nutraceuticals, are pleased to announce that they have signed a strategic alliance agreement to identify and potentially transfer proprietary technologies. Metagenics and BioMeridian Form Partnership Metagenics Inc. and BioMeridian Corp. have announced the formation of a partnership to provide health practitioners with a newly developed software tool named "BioRep(TM)", designed to assist practitioners to assess patients' health and recommend an optimal supplementation protocol. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Edison, New Jersey, August 2nd 2006 – Carotech Inc. announces that it has today entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBioTM – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America (the 'Agreement'). Tocotrienols are a form of vitamin E found in minimal concentrations in plants that have been suggested in scientific studies to offer neuro-protective benefits. Most fat-soluble phytonutrients and antioxidants are poorly absorbed, which results in poor bioavailability. Thus consumers are not getting the optimal benefits, or it takes a longer period of supplementation to see the associated health effects. Responding to demands from customers worldwide, Carotech embarked on an extensive, 3-year research and development effort to add value and develop novel delivery systems for optimal absorption of tocotrienols. Carotech’s main objective is to offer customers a system that ensures maximum absorption of tocotrienols to reach a therapeutic level at a lower dosage. Carotech, the leading and largest producer of tocotrienols in the world, was granted a US patent for a unique, bio-enhanced, natural, full-spectrum palm tocotrienol complex that guarantees an increase in blood plasma absorption of tocotrienols by an average of 250% when compared to regular tocotrienol oil extract. Carotech will collaborate with Metagenics to formulate new and unique products with Tocomin® SupraBioTM, as well as to establish the best commercialization strategy for introducing this novel tocotrienol complex to the healthcare practitioner channel of distribution in North America. The first Metagenics formula featuring Tocomin® SupraBioTM will be a neurological support product for healthy brain function slated for a Fall 2006 launch. Metagenics, a privately held company, was founded in 1983 with the mission to help patients achieve their genetic potential through targeted nutrition. As the leading developer and manufacturer of natural, science-based nutraceuticals, Metagenics markets its products to healthcare practitioners as innovative approaches to leading health issues. The Agreement provides Metagenics with the exclusive right to market Tocomin® SupraBioTM to healthcare professionals, with an option to extend this exclusivity subject to Metagenics’ achievement of certain performance criteria. “This agreement with Metagenics is of great significance to Carotech in that it recognizes the commercial potential of Tocomin® SupraBioTM in the North American healthcare practitioner market. Metagenics will be among the first in the market with this patented bio-enhanced tocotrienol system. We definitely look forward to collaborating with Metagenics, a reputable and experienced nutraceutical company and an ideal long-term strategic partner,” said WH Leong, Vice President, Carotech Inc. “At Metagenics, we evaluate new ingredients carefully using an in-depth evaluation process that recognizes several aspects of a product, including safety and efficacy,” said Dr. Deanna Minich, Director of Technology and Program Integration at Metagenics, Inc. “Carotech’s Tocamin® SupraBio™ is a superior source of tocotrienols and has been well-tested in several studies for its ability to protect nerve cells. We look forward to providing our healthcare practitioner customers with this high quality ingredient.” About Carotech Inc. Carotech Inc. is a wholly owned subsidiary of Carotech Bhd, Malaysia. Carotech, a public listed company in Malaysia (Malaysian Securities Exchange Board under the high-technology / high growth, MESDAQ Board), is the largest producer of tocotrienol in the world via its patented technology. Carotech Bhd is a subsidiary of Hovid Bhd., one of the largest GMP-certified pharmaceutical companies in Malaysia (www.hovid.com). Tocomin® and Tocomin® SupraBioTM are registered trademarks of Carotech Inc. and protected by US Patent Nos : 5,157,132 and 6,596,306. www.carotech.net About Metagenics, Inc. Metagenics, Inc. is a leading developer and manufacturer of science-based nutraceuticals sold to healthcare practitioners worldwide as approaches to leading health concerns. The company is headquartered in San Clemente, Calif., with manufacturing and multiple research facilities located in Gig Harbor, Wash.—including its MetaProteomics® Nutrigenomics Research Center and its Functional Medicine Research CenterSM for human clinical research. Metagenics holds multiple proprietary formula patents and produces over 400 research-based products to optimize health. The company demonstrates its commitment to purity and quality through its certifications for Good Manufacturing Practices (GMP) from the NNFA, NSF International, and TGA. For more information about Metagenics, please visit the company’s Web site at www.metagenics.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software